Division of Nephrology, Washington University School of Medicine, St. Louis, Missouri, United States of America.
PLoS One. 2022 Jun 28;17(6):e0270008. doi: 10.1371/journal.pone.0270008. eCollection 2022.
CRISPR/Cas9-mediated transcriptional activation (CRISPRa) is a powerful tool for investigating complex biological phenomena. Although CRISPRa approaches based on the VP64 transcriptional activator have been widely studied in both cultured cells and in animal models and exhibit great versatility for various cell types and developmental stages in vivo, different dCas9-VP64 versions have not been rigorously compared. Here, we compared different dCas9-VP64 constructs in identical contexts, including the cell lines used and the transfection conditions, for their ability to activate endogenous and exogenous genes. Moreover, we investigated the optimal approach for VP64 addition to VP64- and p300-based constructs. We found that MS2-MCP-scaffolded VP64 enhanced basal dCas9-VP64 and dCas9-p300 activity better than did direct VP64 fusion to the N-terminus of dCas9. dCas9-VP64+MCP-VP64 and dCas9-p300+MCP-VP64 were superior to VP64-dCas9-VP64 for all target genes tested. Furthermore, multiplexing gRNA expression with dCas9-VP64+MCP-VP64 or dCas9-p300+MCP-VP64 significantly enhanced endogenous gene activation to a level comparable to CRISPRa-SAM with a single gRNA. Our findings demonstrate improvement of the dCas9-VP64 CRISPRa system and contribute to development of a versatile, efficient CRISPRa platform.
CRISPR/Cas9 介导的转录激活(CRISPRa)是研究复杂生物现象的有力工具。虽然基于 VP64 转录激活剂的 CRISPRa 方法已在培养细胞和动物模型中得到广泛研究,并在体内各种细胞类型和发育阶段表现出极大的多功能性,但不同的 dCas9-VP64 版本尚未得到严格比较。在这里,我们在相同的背景下比较了不同的 dCas9-VP64 构建体,包括所使用的细胞系和转染条件,以评估它们激活内源性和外源性基因的能力。此外,我们还研究了在 VP64 和 p300 基构建体中添加 VP64 的最佳方法。我们发现 MS2-MCP 支架化的 VP64 比直接融合到 dCas9 的 N 端更能增强基础 dCas9-VP64 和 dCas9-p300 的活性。对于所有测试的靶基因,dCas9-VP64+MCP-VP64 和 dCas9-p300+MCP-VP64 均优于 VP64-dCas9-VP64。此外,用 dCas9-VP64+MCP-VP64 或 dCas9-p300+MCP-VP64 共表达 gRNA 表达显著增强了内源性基因的激活,使其达到与使用单个 gRNA 的 CRISPRa-SAM 相当的水平。我们的研究结果表明,dCas9-VP64 CRISPRa 系统得到了改进,并有助于开发一种多功能、高效的 CRISPRa 平台。